Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | EGLN1 | Q9GZT9 | 3/20 | 0.47 |
| ▸ | LDHA | P00338 | 1/20 | 0.47 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.47 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.47 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.47 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.41 |
| ▸ | CTH | P32929 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.39 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | KDM5C | P41229 | 2/20 | 0.38 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.38 |
| ▸ | KDM2A | Q9Y2K7 | 2/20 | 0.38 |
| ▸ | KDM6B | O15054 | 1/20 | 0.38 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 2/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL284371 | 1.00 | LMNA (0.47) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL29262203 | 0.96 | LMNA (0.44) | LMNAEGLN1LDHASRRALKBH5 | |
| Water SCHEMBL10705898 | 0.96 | LMNA (0.44) | LMNAEGLN1LDHASRRALKBH5 | |
| Water SCHEMBL27594738 | 0.96 | LMNA (0.44) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL27023 | 0.96 | — | — | |
| SCHEMBL4816014 | 0.96 | LMNA (0.50) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL735923 | 0.93 | — | — | |
| SCHEMBL3464176 | 0.92 | LMNA (0.47) | LMNAEGLN1LDHASRRALKBH5 | |
| Ammonia Solution, Strong SCHEMBL7262621 | 0.92 | LMNA (0.47) | LMNAEGLN1LDHASRRALKBH5 | |
| SCHEMBL9393647 | 0.92 | LMNA (0.47) | LMNAEGLN1LDHASRRALKBH5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250091013-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | MONSANTO TECHNOLOGY LLC | 2025-03-20 | — | — | US | claimed |
| CN-119481578-A | Sodium ion battery diaphragm coating slurry, coated diaphragm and sodium ion battery | 湖南裕能新能源电池材料股份有限公司 | 2025-02-18 | — | — | CN | claimed |
| US-12186709-B2 | Three-compartment bipolar membrane electrodialysis of salts of amino acids | MONSANTO TECHNOLOGY LLC (US) | 2025-01-07 | — | — | US | claimed |
| US-20240158423-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | MONSANTO TECHNOLOGY LLC | 2024-05-16 | — | — | US | claimed |
| EP-4301763-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | Monsanto Technology LLC (US) | 2024-01-10 | — | — | EP | claimed |
| WO-2022187407-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | MONSANTO TECHNOLOGY LLC (US) | 2022-09-09 | — | — | WO | claimed |
| US-20210229040-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | MONSANTO TECHNOLOGY LLC | 2021-07-29 | — | — | US | claimed |
| EP-3801843-A1 | THREE-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | Monsanto Technology LLC (US) | 2021-04-14 | — | — | EP | claimed |
| EP-1282596-B1 | PREPARATION OF IMINODIACETIC ACID COMPOUNDS FROM MONOETHANOLAMINE SUBSTRATES | MONSANTO TECHNOLOGY LLC (US) | 2006-08-30 | — | — | EP | claimed |
| EP-1684900-A1 | TRANSITION METAL CARBIDE AND NITRIDE CONTAINING CATALYSTS, THEIR PREPARATION AND USE AS OXIDATION AND DEHYDROGENATION CATALYSTS | Monsanto Technology LLC (US) | 2006-08-02 | — | — | EP | claimed |
| US-6376708-B1 | USING COPPER, OR ALLOY THEREOF, AS CATALYST | MONSANTO TECHNOLOGY LLC | 2002-04-23 | — | — | US | claimed |
| US-20020019564-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | MONSANTO COMPANY | 2002-02-14 | — | — | US | claimed |
| US-20020019565-A1 | Process for making iminodiacetic acid compounds from monoethanolamine substrates | MONSANTO TECHNOLOGY LLC | 2002-02-14 | — | — | US | claimed |
| WO-2001087827-A1 | PREPARATION OF IMINODIACETIC ACID COMPOUNDS FROM MONOETHANOLAMINE SUBSTRATES | MONSANTO TECHNOLOGY LLC (US) | 2001-11-22 | — | — | WO | claimed |
| WO-2001077054-A2 | PROCESS AND CATALYST FOR DEHYDROGENATING PRIMARY ALCOHOLS TO MAKE CARBOXYLIC ACID SALTS | MONSANTO TECHNOLOGY LLC (US) | 2001-10-18 | — | — | WO | claimed |
| JP-2001508043-A | — | — | 2001-06-19 | — | — | JP | claimed |
| US-5986128-A | ACIDIFICATION AND PHOSPHONATION | MONSANTO COMPANY (US) | 1999-11-16 | — | — | US | claimed |
| EP-0935595-A1 | USE OF MONOSODIUM IMINODIACETIC ACID SOLUTIONS IN THE PREPARATION OF N-PHOSPHONOMETHYLIMINODIACETIC ACID | MONSANTO COMPANY (US) | 1999-08-18 | — | — | EP | claimed |
| WO-1998019992-A1 | USE OF MONOSODIUM IMINODIACETIC ACID SOLUTIONS IN THE PREPARATION OF N-PHOSPHONOMETHYLIMINODIACETIC ACID | MONSANTO COMPANY (US) | 1998-05-14 | — | — | WO | claimed |
| EP-0165728-B1 | NMR CONTRAST AGENTS | NYCOMED AS (NO) | 1988-12-14 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12186709-B2 | Three-compartment bipolar membrane electrodialysis of salts of amino acids | SLC1A3, SLC1A2, SLC1A1 | LMNA 2289/4885EGLN1 4206/4885LDHA 2100/4885 |
| US-20250091013-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | SLC1A3, SLC1A2, SLC1A1 | LMNA 2289/4885EGLN1 4206/4885LDHA 2100/4885 |
| US-20240158423-A1 | TWO-COMPARTMENT BIPOLAR MEMBRANE ELECTRODIALYSIS OF SALTS OF AMINO ACIDS | SLC1A2, SLC5A11, SLC3A2 | LMNA 1329/4885EGLN1 4766/4885LDHA 1657/4885 |
| US-20210229040-A1 | Three-Compartment Bipolar Membrane Electrodialysis Of Salts Of Amino Acids | SLC1A3, SLC1A2, SLC1A1 | LMNA 2289/4885EGLN1 4206/4885LDHA 2100/4885 |
| US-20020019565-A1 | Process for making iminodiacetic acid compounds from monoethanolamine substrates | INMT, NAAA, PNMT | LMNA 703/4885EGLN1 845/4885LDHA 754/4885 |
| US-20020019564-A1 | Process and catalyst for dehydrogenating primary alcohols to make carboxylic acid salts | ADH1A, ADH1C, ADH5 | LMNA 3280/4885EGLN1 1981/4885LDHA 57/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.